AnPac Bio-Medical Science Co., Ltd (ANPC): NASDAQ hearing on the 20th matters but F...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: D-bol post# 67

Thursday, 10/13/2022 4:19:41 PM

Thursday, October 13, 2022 4:19:41 PM

NASDAQ hearing on the 20th matters but FDA approval will =$$$$$. Always a risk.

ANPC

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 12:03:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 08:23:50 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/02/2024 01:01:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2024 08:12:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2024 08:06:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2024 08:05:33 PM
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 03/25/2024 08:02:21 PM
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' • PR Newswire (US) • 05/19/2023 04:55:00 PM
Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022 • PR Newswire (US) • 05/16/2023 09:00:00 PM
Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results • PR Newswire (US) • 05/16/2023 08:15:00 PM
Fresh2 Reports Fiscal Year 2022 Annual Financial Results • PR Newswire (US) • 05/16/2023 08:15:00 PM

InvestorsHub NewsWire

Only $200 per official company press release!